title: [Relapse of pulmonary tuberculosis in the context of tuberculosis-HIV co-infection in Abidjan (Côte d'Ivoire). Short note].
abstract: A cohort study was carried out from October 2001 to March 2002, in order to analyze the main characteristics of 53 adults patients (38 HIV-positive and 15 HIV-negative), who had a relapse of pulmonary tuberculosis. The observance in the first period of the treatment of tuberculosis was regular in 79% of tuberculous patients infected by the HIV (30/38) and in 87% of tuberculous patients who where HIV-negative (13/15) (p = 0.7). The relapse occurred before one year after recovery in 74% among the HIV-positive (28/38) and in 33% among the HIV-negative patients (5/15) (p = 0.00). Most of the HIV-positive patients (74%) had CD4 counts under 200/mm3 and 80% of the HIV-negative patients had more than 500 CD4 counts/mm3 (p = 0.00). After two months of retreatment following the relapse diagnosis, the rate of improvement in patients was about 16% in HIV infected (6/38) and about 67% in HIV-negative patients (10/15) (p = 0.00).
authors.affiliation: Service de pneumo-phtisiologie, CHU de Treichville, B.P V 3 Abidjan, Côte d'Ivoire. kouaomd@yahoo.fr
authors.forename: K
authors.initials: K
authors.lastname: Domoua
authors.forename: T
authors.initials: T
authors.lastname: Daix
authors.forename: G
authors.initials: G
authors.lastname: Coulibaly
authors.forename: A
authors.initials: A
authors.lastname: Bakayoko
authors.forename: A
authors.initials: A
authors.lastname: Kassi
authors.forename: H
authors.initials: H
authors.lastname: M'bouandi
authors.forename: L K
authors.initials: LK
authors.lastname: Beugre
authors.forename: M
authors.initials: M
authors.lastname: Traore
authors.forename: A
authors.initials: A
authors.lastname: Yapi
mesh_terms: D000293:Adolescent; D000328:Adult; D018791:CD4 Lymphocyte Count; D007560:Cote d'Ivoire; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D014397:Tuberculosis, Pulmonary / Q000150:complications*